Psyence Biomedical Ltd. (PBM) Invested Capital (2024 - 2026)

Psyence Biomedical's Invested Capital history runs 3 years deep, the most recent figure standing at $407714.0 for Q1 2026.

• In Q1 2026, Invested Capital rose 3.41% year-over-year to $407714.0; the TTM figure through Mar 2026 stood at $2.9 million (down 78.27% YoY), while the FY2026 annual figure was $407714.0, up 3.41% from the prior year.
• Invested Capital for Q1 2026 stood at $407714.0, down from $644700.0 in the prior quarter.
• The five-year high for Invested Capital was $11.4 million in Q1 2024, with the low at $394270.0 in Q1 2025.
• The 3-year median for Invested Capital is $644700.0 (2025), against an average of $2.9 million.
• The sharpest annual moves came in 2025 and 2026: Invested Capital sank 96.56% in 2025, then increased 3.41% in 2026.
• Psyence Biomedical's Invested Capital stood at $1.4 million in 2024, then plunged by 55.21% to $644700.0 in 2025, then plunged by 36.76% to $407714.0 in 2026.
• Business Quant data shows PBM's Invested Capital at $407714.0 in Q1 2026, $644700.0 in Q3 2025, and $394270.0 in Q1 2025.